BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37560806)

  • 21. [GnRH agonists and antagonists in the preoperative therapy of uterine fibroids: literature review].
    De Falco M; Pollio F; Pontillo M; Ambrosino E; Busiello A; Carbone IF; Ciociola F; Di Nardo MA; Landi L; Di Lieto A
    Minerva Ginecol; 2006 Dec; 58(6):553-60. PubMed ID: 17108883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of ulipristal acetate in female patients with uterine fibroids.
    Grzechocinska B; Gadomska H; Zygula A; Wielgos M
    Neuro Endocrinol Lett; 2014; 35(3):175-8. PubMed ID: 24977963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids.
    Evangelisti G; Barra F; Perrone U; Di Donato N; Bogliolo S; Ceccaroni M; Ferrero S
    Expert Opin Drug Metab Toxicol; 2022; 18(7-8):441-457. PubMed ID: 35968602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Will GnRH antagonists assist in the treatment of benign gynaecological diseases?
    Felberbaum RE; Küpker W; Diedrich K
    Reprod Biomed Online; 2002; 5 Suppl 1():68-72. PubMed ID: 12537785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimising menopausal side effects whilst treating endometriosis and fibroids.
    Simpson PD; McLaren JS; Rymer J; Morris EP
    Post Reprod Health; 2015 Mar; 21(1):16-23. PubMed ID: 25802141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herbal preparations for uterine fibroids.
    Liu JP; Yang H; Xia Y; Cardini F
    Cochrane Database Syst Rev; 2013 Apr; (4):CD005292. PubMed ID: 23633329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of GnRH analogues pre-treatment on myomectomy outcomes in reproductive age women].
    Hudecek R; Ivanová Z; Smerdová M; Pánková S; Krajcovicová R
    Ceska Gynekol; 2012 Apr; 77(2):109-17. PubMed ID: 22702067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of uterine fibroids with GnRH-analogues prior to hysterectomy.
    Stjernquist M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():94-7. PubMed ID: 9225649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of GnRH agonists in the treatment of uterine fibroids.
    Healy DL; Vollenhoven BJ
    Br J Obstet Gynaecol; 1992 Feb; 99 Suppl 7():23-6. PubMed ID: 1554685
    [No Abstract]   [Full Text] [Related]  

  • 31. Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials.
    Donnez J; Taylor HS; Stewart EA; Bradley L; Marsh E; Archer D; Al-Hendy A; Petraglia F; Watts N; Gotteland JP; Bestel E; Terrill P; Loumaye E; Humberstone A; Garner E
    Lancet; 2022 Sep; 400(10356):896-907. PubMed ID: 36116480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonadotrophin hormone-releasing hormone analogue treatment of fibroids.
    Shaw RW
    Baillieres Clin Obstet Gynaecol; 1998 Jun; 12(2):245-68. PubMed ID: 10023421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids.
    Syed YY
    Drugs; 2022 Oct; 82(15):1549-1556. PubMed ID: 36331779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical practice. Uterine fibroids.
    Stewart EA
    N Engl J Med; 2015 Apr; 372(17):1646-55. PubMed ID: 25901428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice?
    Donnez J; Donnez O; Dolmans MM
    Fertil Steril; 2014 Sep; 102(3):640-8. PubMed ID: 25106762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas.
    Neblett MF; Stewart EA
    Obstet Gynecol; 2023 May; 141(5):901-910. PubMed ID: 37103532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New treatment options for nonsurgical management of uterine fibroids.
    Lee S; Stewart EA
    Curr Opin Obstet Gynecol; 2023 Aug; 35(4):288-293. PubMed ID: 37144584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential role of elagolix for treating uterine bleeding associated to uterine myomas.
    Barra F; Vitale SG; Seca M; Scala C; Leone Roberti Maggiore U; Cianci A; Ferrero S
    Expert Opin Pharmacother; 2020 Aug; 21(12):1419-1430. PubMed ID: 32401547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ulipristal Acetate: A Review in Symptomatic Uterine Fibroids.
    Garnock-Jones KP; Duggan ST
    Drugs; 2017 Oct; 77(15):1665-1675. PubMed ID: 28900897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.